永安药业(002365.SZ)发布上半年业绩，归母净利润1249.57万元，同比下降76.19%

Core Viewpoint - Yong'an Pharmaceutical (002365.SZ) reported a significant decline in both revenue and net profit for the first half of 2025, indicating potential challenges in its operational performance [1] Financial Performance - The company achieved operating revenue of 367 million yuan, a year-on-year decrease of 13.72% [1] - The net profit attributable to shareholders was 12.4957 million yuan, reflecting a year-on-year decline of 76.19% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 2.2853 million yuan, down 93.65% year-on-year [1] - Basic earnings per share were reported at 0.0432 yuan [1]